International Society For Cellular Therapy

International Society for Cellular Therapy (ISCT) Leads Roundtable With Major US Payors, Healthcare Providers and Industry to Initiate a Collaboration to Address Cell Therapy Product Reimbursement

International Society for Cellular Therapy (ISCT) Launches Inaugural Cell Therapy Commercial Development Focus Group on Peripheral Vascular Disease

International Society for Cellular Therapy (ISCT) Joins Forces With Roche and Genzyme to Launch Cell Therapy Industry Partnership

VANCOUVER, September 29, 2011 - The interest of many insured US citizens was represented by participation of payor organizations including Anthem Blue Cross Blue Shield, LifeTrac and OptumHealth.

MORE..

VANCOUVER, January 19, 2011 - In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT announces its first commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease (PVD).

MORE..

Older News

VANCOUVER, August 16, 2010 - Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development.

MORE..